S82959 |
KH-CB19 |
源叶(MedMol) | 99% |
- 提示:详情请下载说明书。
- 产品描述: KH-CB19 is a potent CLK (cdc2-like kinase) inhibitor (CLK1 IC50=19.7 nM; CLK3 IC50=530 nM). KH-CB19 shows antiviral activity and inhibits influenza virus replication (IC50=13.6 μM)
- 靶点: CLK1:19.7 nM (IC50);CLK3:530 nM (IC50);DYRK1A:55.2 nM (IC50);Others
- 体外研究:
KH-CB19 (10 μM; 1 h) shows CLK inhibition on SR protein phosphorylation in human microvascular endothelial cells. KH-CB19 (50 μM; 6 h) inhibits the disruption by CLK4 in A549 cells. Western Blot Analysis Cell Line: Human microvascular endothelial cells (HMEC-1) Concentration: 10 μM Incubation Time: 1 hour Result: Led to a reduced phosphorylation of SRp75, SRp55, and SRp20 compared with non TNF-α-stimulated controls.Led to a reduction of the TNF-α-induced increase in phosphorylation of all analyzed SR proteins compared with TNF-α-stimulated controls.
- 参考文献:
1. Fedorov O, et al. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol. 2011 Jan 28;18(1):67-76. 2. Artarini A, et al. Regulation of influenza A virus mRNA splicing by CLK1. Antiviral Res. 2019 Aug;168:187-196.
- 溶解性: soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.957 ml 14.785 ml 29.569 ml 5 mM 0.591 ml 2.957 ml 5.914 ml 10 mM 0.296 ml 1.478 ml 2.957 ml 50 mM 0.059 ml 0.296 ml 0.591 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)